IMU is making tremendous progress and does not need the distractions and disruptions from a consolidation to attempt to influence the share prices.
The share prices will improve based on fda approvals, bp interests, deals, licencing, partnership, etc.
Consolidation will not hasten the progress of the real business of improving IMU's assets ie. Cancer treatments.
not interested in analysing WBT's consolidation and subsequent 'improvements' in its share prices which could have been caused by various factors other than consolidation, like its technologies, deals etc.
cobsoludation is not the answers, efficacy and fda approvals are.
imho.
Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals, page-274
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $1.040M | 18.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1917207 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 653942 | 7 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |